About
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. The firm manages approximately $1.7 billion of capital in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners provides growth equity, growth recapitalization, and management buyout financing to growing healthcare companies. They invest in innovative healthcare companies with a demonstrated track record of both revenue and profit growth, targeting companies with $10-100 million in revenue and $2-12 million in EBITDA. Great Point Partners also actively sources tuck-in acquisition opportunities for its portfolio companies.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Great Point Partners' primary investment focus?
- Great Point Partners focuses on the financial services sector, as indicated by its one-liner and about section.
- Which sectors does Great Point Partners primarily invest in?
- Great Point Partners primarily invests in the Health Tech & Life Sciences sector, with two portfolio companies in this area.
- Can you name some of Great Point Partners' portfolio companies?
- Great Point Partners' portfolio includes UroGen Pharma, which focuses on.
- What is Great Point Partners' investment range?
- Great Point Partners' investment range is between $11.06M and $120M.
- When did Great Point Partners make its most recent recorded investment?
- Great Point Partners made its most recent recorded investment in July 2023.
- What funding stages does Great Point Partners typically participate in?
- Great Point Partners has participated in A Round and PIPE funding stages.
- What was Great Point Partners' earliest recorded investment?
- Great Point Partners' earliest recorded investment was in November 2016.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2003 |
|---|